ArticleJournal for immunotherapy of cancer2022

A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL.

Naveen K Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.